By David GilesSenior Web Producer Global News
REGINA – Two new drugs to treat hepatitis C have been approved for coverage in Saskatchewan. The government announced Wednesday that Harvoni and Sovaldi, which have high success rates in treating hepatitis C, will be available to patients in the province.
The new drugs cure 90 to 98 per cent of patients in as little as eight to 12 weeks. Traditional therapies cure 60 to 75 per cent of patients in 24 to 48 weeks.
“These two drugs offer effective, simple and fast treatment,” said Saskatchewan Health Minister Dustin Duncan.
No comments:
Post a Comment